Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Michael Handler

Concepts (494)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms
28
2023
1163
2.460
 Why?
Ependymoma
16
2024
176
1.890
 Why?
Hydrocephalus
5
2022
108
1.530
 Why?
Neural Tube Defects
3
2021
63
1.330
 Why?
Brain Stem Neoplasms
8
2018
89
1.320
 Why?
Neurosurgical Procedures
7
2023
170
1.280
 Why?
Decompression, Surgical
4
2022
99
1.210
 Why?
Neurosurgery
2
2023
37
1.190
 Why?
Magnetic Resonance Imaging
18
2023
3371
1.130
 Why?
Arnold-Chiari Malformation
4
2022
31
1.110
 Why?
Glioma
7
2021
353
1.050
 Why?
Craniopharyngioma
8
2020
82
0.970
 Why?
Cerebrospinal Fluid Shunts
5
2017
32
0.960
 Why?
Spinal Injuries
2
2019
52
0.950
 Why?
Child
70
2025
20636
0.850
 Why?
Germinoma
2
2022
13
0.850
 Why?
Epilepsy
6
2025
322
0.820
 Why?
Pineal Gland
1
2022
17
0.800
 Why?
Pinealoma
1
2022
11
0.800
 Why?
Child, Preschool
49
2025
10378
0.720
 Why?
Infratentorial Neoplasms
5
2024
60
0.680
 Why?
Meningomyelocele
4
2022
58
0.600
 Why?
Infant
39
2024
8912
0.600
 Why?
Pituitary Neoplasms
5
2020
183
0.600
 Why?
Tomography, X-Ray Computed
9
2020
2509
0.580
 Why?
Skull Neoplasms
1
2017
23
0.580
 Why?
Neuroblastoma
3
2024
153
0.570
 Why?
Medulloblastoma
6
2022
198
0.560
 Why?
Cerebellar Neoplasms
5
2022
156
0.550
 Why?
Humans
111
2025
128020
0.540
 Why?
Sarcoma, Ewing
1
2017
87
0.530
 Why?
Astrocytoma
7
2013
120
0.490
 Why?
Colectomy
1
2016
93
0.480
 Why?
Ganglioglioma
4
2016
31
0.480
 Why?
Gene Expression Regulation, Neoplastic
13
2022
1343
0.480
 Why?
Ventriculoperitoneal Shunt
3
2019
37
0.480
 Why?
Female
64
2025
68017
0.470
 Why?
Adolescent
42
2025
20158
0.470
 Why?
Male
60
2025
62758
0.470
 Why?
Rhabdoid Tumor
3
2013
97
0.460
 Why?
Gene Expression Profiling
15
2020
1681
0.450
 Why?
Child Abuse
4
2015
517
0.450
 Why?
Craniotomy
2
2012
68
0.450
 Why?
Reoperation
2
2016
541
0.450
 Why?
Retrospective Studies
29
2024
14404
0.440
 Why?
Wounds, Nonpenetrating
2
2019
271
0.440
 Why?
Pleural Cavity
1
2013
1
0.440
 Why?
Biomarkers, Tumor
8
2018
1175
0.440
 Why?
Cerebral Cortex
1
2017
422
0.430
 Why?
Supratentorial Neoplasms
3
2019
19
0.430
 Why?
Colitis
1
2016
240
0.420
 Why?
Neoplasm Recurrence, Local
5
2014
955
0.410
 Why?
Crohn Disease
1
2016
206
0.400
 Why?
Pons
4
2015
30
0.400
 Why?
Image Processing, Computer-Assisted
2
2020
734
0.400
 Why?
Infant, Newborn
20
2024
5688
0.390
 Why?
Accidents
1
2012
39
0.380
 Why?
Teratoma
2
2011
103
0.380
 Why?
Treatment Outcome
19
2024
10110
0.360
 Why?
Brain Injuries
2
2015
463
0.360
 Why?
Prognosis
18
2024
3766
0.340
 Why?
Spinal Cord Neoplasms
4
2024
38
0.340
 Why?
Cervical Vertebrae
2
2015
132
0.340
 Why?
Head Injuries, Closed
1
2010
50
0.330
 Why?
Central Nervous System
2
2014
254
0.330
 Why?
Membrane Proteins
3
2012
1105
0.320
 Why?
Proto-Oncogene Proteins B-raf
3
2017
212
0.310
 Why?
Antineoplastic Combined Chemotherapy Protocols
8
2024
1558
0.300
 Why?
Chromosomes, Human, Pair 1
2
2019
70
0.300
 Why?
Syringomyelia
2
2011
12
0.290
 Why?
Cerebrospinal Fluid
2
2007
89
0.290
 Why?
Oligonucleotide Array Sequence Analysis
12
2016
755
0.290
 Why?
Postoperative Complications
6
2022
2456
0.290
 Why?
Intracranial Hemorrhages
2
2015
79
0.290
 Why?
Spinal Neoplasms
2
2024
29
0.270
 Why?
RNA, Messenger
9
2017
2669
0.270
 Why?
Transcriptome
5
2022
879
0.260
 Why?
Vancomycin
1
2007
78
0.250
 Why?
Cell Line, Tumor
11
2018
3168
0.250
 Why?
Onchocerciasis
2
2015
7
0.250
 Why?
Chloroquine
2
2017
52
0.250
 Why?
Proto-Oncogene Proteins
3
2016
632
0.240
 Why?
Subdural Effusion
1
2024
4
0.240
 Why?
Cerebral Hemorrhage
2
2017
106
0.230
 Why?
Neocortex
1
2025
33
0.230
 Why?
Pyramidal Cells
1
2025
70
0.230
 Why?
Intraoperative Complications
2
1996
129
0.230
 Why?
Immunophenotyping
2
2017
309
0.230
 Why?
Laparoscopy
1
2008
450
0.220
 Why?
Glioblastoma
4
2013
323
0.220
 Why?
Drainage
1
2024
165
0.220
 Why?
Attitude of Health Personnel
1
2011
1088
0.210
 Why?
Neurosurgeons
1
2023
17
0.210
 Why?
Autophagy
2
2017
265
0.210
 Why?
Tumor Suppressor Proteins
3
2017
313
0.210
 Why?
Adult
22
2020
35177
0.210
 Why?
Nuclear Proteins
3
2017
657
0.210
 Why?
Patients' Rooms
1
2022
13
0.200
 Why?
Indoles
2
2017
371
0.200
 Why?
Osteosarcoma
1
2003
72
0.200
 Why?
Cell Proliferation
8
2019
2337
0.200
 Why?
Narcotics
1
2022
45
0.200
 Why?
Electroencephalography
4
2018
396
0.200
 Why?
Cell Cycle Proteins
3
2016
578
0.200
 Why?
Combined Modality Therapy
7
2015
1199
0.190
 Why?
Histiocytosis, Langerhans-Cell
1
2022
36
0.190
 Why?
Sulfonamides
2
2017
494
0.190
 Why?
Drug Resistant Epilepsy
2
2025
83
0.190
 Why?
Drug Screening Assays, Antitumor
2
2021
195
0.190
 Why?
Radiation
1
2021
24
0.190
 Why?
Follow-Up Studies
8
2024
4853
0.180
 Why?
SEER Program
4
2018
206
0.180
 Why?
Chemoradiotherapy
2
2019
209
0.180
 Why?
Scoliosis
2
2011
201
0.180
 Why?
Lumbosacral Region
1
2021
56
0.180
 Why?
Antineoplastic Agents
3
2018
2041
0.180
 Why?
Parietal Bone
1
2000
9
0.180
 Why?
Transcription Factor RelA
2
2019
79
0.180
 Why?
Chromosome Aberrations
2
2017
148
0.180
 Why?
Connective Tissue
1
2000
38
0.180
 Why?
Skull Fractures
1
2000
33
0.180
 Why?
Inclusion Bodies
2
2012
25
0.170
 Why?
Epilepsies, Partial
2
2018
46
0.170
 Why?
Neoplastic Cells, Circulating
1
2020
70
0.170
 Why?
Diagnosis, Computer-Assisted
1
2020
87
0.170
 Why?
Reverse Transcriptase Polymerase Chain Reaction
6
2014
940
0.160
 Why?
Biopsy
3
2018
1077
0.160
 Why?
Data Collection
2
2014
645
0.160
 Why?
Obstetric Surgical Procedures
1
2019
6
0.160
 Why?
Prenatal Care
2
2022
274
0.160
 Why?
Positron-Emission Tomography
2
2018
283
0.160
 Why?
Optic Nerve Neoplasms
1
2019
12
0.160
 Why?
Optic Chiasm
1
2019
19
0.160
 Why?
Fetal Therapies
1
2019
32
0.160
 Why?
Pteridines
2
2016
22
0.150
 Why?
Maternal Health
1
2019
46
0.150
 Why?
Neoplasm Staging
4
2024
1288
0.150
 Why?
Microarray Analysis
5
2017
120
0.150
 Why?
Astrocytes
2
2012
188
0.150
 Why?
Single-Cell Analysis
1
2020
270
0.140
 Why?
Central Nervous System Neoplasms
2
2015
148
0.140
 Why?
Hysterotomy
1
2017
10
0.140
 Why?
Occipital Lobe
1
2017
24
0.140
 Why?
Cyst Fluid
1
2017
26
0.140
 Why?
Fetoscopy
1
2017
27
0.140
 Why?
Disease Management
1
2021
583
0.140
 Why?
Fluorodeoxyglucose F18
1
2018
127
0.140
 Why?
Chordoma
1
2017
16
0.140
 Why?
Skull Base Neoplasms
1
2017
24
0.140
 Why?
Meningioma
1
2018
80
0.140
 Why?
Equipment Failure
2
2013
107
0.140
 Why?
Meningeal Neoplasms
1
2018
93
0.140
 Why?
Neoadjuvant Therapy
1
2019
381
0.130
 Why?
Tuberous Sclerosis
1
2017
49
0.130
 Why?
Checkpoint Kinase 1
1
2016
31
0.130
 Why?
Neuroimaging
1
2019
278
0.130
 Why?
Electrocoagulation
1
1996
38
0.130
 Why?
Neoplasm Proteins
2
2012
419
0.130
 Why?
Tissue Banks
1
2016
14
0.130
 Why?
Radiation-Sensitizing Agents
1
2016
40
0.130
 Why?
Electrodes, Implanted
1
2017
104
0.130
 Why?
Frontal Lobe
1
2017
153
0.130
 Why?
Drug Resistance, Neoplasm
3
2017
744
0.130
 Why?
Survival Rate
6
2024
1870
0.130
 Why?
Onchocerca
1
2015
3
0.130
 Why?
B7-H1 Antigen
1
2018
189
0.130
 Why?
Myeloid Cells
2
2015
142
0.130
 Why?
Young Adult
12
2021
12282
0.120
 Why?
Zoonoses
1
2015
27
0.120
 Why?
Ketorolac
1
2015
18
0.120
 Why?
Communicable Diseases, Emerging
1
2015
30
0.120
 Why?
EGF Family of Proteins
1
2015
17
0.120
 Why?
Decision Support Techniques
1
2019
396
0.120
 Why?
Dog Diseases
1
2015
52
0.120
 Why?
Receptor, EphA2
1
2015
20
0.120
 Why?
Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
1
2015
22
0.120
 Why?
Algorithms
2
2020
1609
0.120
 Why?
Receptor, ErbB-3
1
2015
45
0.120
 Why?
Temporal Lobe
1
2015
85
0.120
 Why?
Survivors
2
2023
462
0.120
 Why?
MicroRNAs
2
2012
674
0.120
 Why?
Spinal Cord Diseases
1
2015
40
0.120
 Why?
Cohort Studies
8
2021
5378
0.120
 Why?
Risk Factors
7
2019
9696
0.120
 Why?
Choroid Plexus Neoplasms
1
2014
9
0.120
 Why?
Lumbar Vertebrae
1
2016
230
0.120
 Why?
Image Interpretation, Computer-Assisted
1
2016
253
0.120
 Why?
Ventriculostomy
1
1994
22
0.120
 Why?
src-Family Kinases
1
2015
95
0.110
 Why?
Endoscopes
1
1994
18
0.110
 Why?
Recurrence
2
2016
993
0.110
 Why?
Encephalitis
1
2016
132
0.110
 Why?
Cytokines
3
2017
1984
0.110
 Why?
Radiation Tolerance
2
2012
97
0.110
 Why?
Kaplan-Meier Estimate
5
2016
851
0.110
 Why?
Perioperative Care
1
2015
149
0.110
 Why?
Accidents, Traffic
2
2012
186
0.110
 Why?
Time Factors
4
2019
6479
0.110
 Why?
Blotting, Western
3
2014
1169
0.110
 Why?
Professional Practice
1
2014
63
0.110
 Why?
NF-kappa B
1
2017
649
0.110
 Why?
Pediatrics
1
2021
1044
0.110
 Why?
STAT3 Transcription Factor
1
2015
190
0.110
 Why?
Foreign-Body Migration
1
2013
35
0.110
 Why?
Catheters
1
2013
66
0.100
 Why?
Proto-Oncogene Proteins c-myc
1
2014
130
0.100
 Why?
Brain
2
2023
2615
0.100
 Why?
B7 Antigens
1
2012
14
0.100
 Why?
Survival Analysis
3
2014
1262
0.100
 Why?
Kidney Neoplasms
2
2017
349
0.100
 Why?
Fatty Liver, Alcoholic
1
2012
16
0.100
 Why?
Neuroectodermal Tumors, Primitive
1
2012
11
0.100
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2015
332
0.100
 Why?
Neurology
1
2014
103
0.100
 Why?
Prevalence
2
2016
2541
0.100
 Why?
Spinal Dysraphism
1
2013
59
0.100
 Why?
Epigenesis, Genetic
2
2017
614
0.100
 Why?
Persistent Vegetative State
1
2012
4
0.100
 Why?
Lipase
1
2012
64
0.100
 Why?
Prospective Studies
5
2024
7035
0.100
 Why?
Drug Delivery Systems
1
2015
327
0.100
 Why?
Cell Survival
4
2017
1073
0.100
 Why?
Immunohistochemistry
3
2013
1663
0.100
 Why?
Rubinstein-Taybi Syndrome
1
2011
2
0.090
 Why?
ErbB Receptors
1
2015
601
0.090
 Why?
Seizures
1
2015
400
0.090
 Why?
Incidence
3
2017
2614
0.090
 Why?
Glasgow Coma Scale
1
2012
167
0.090
 Why?
Disabled Children
1
2012
66
0.090
 Why?
Interleukin-6
1
2015
712
0.090
 Why?
Neurologic Examination
1
2011
115
0.090
 Why?
Bone Morphogenetic Proteins
1
2011
129
0.090
 Why?
Cerebellum
1
2012
217
0.090
 Why?
Heart Arrest
1
1994
307
0.090
 Why?
Body Mass Index
1
2019
2260
0.090
 Why?
Radiosurgery
1
2014
318
0.090
 Why?
Fatty Liver
1
2012
231
0.080
 Why?
Morbidity
2
2018
301
0.080
 Why?
Neoplastic Stem Cells
1
2014
377
0.080
 Why?
Sex Factors
1
2016
1942
0.080
 Why?
Transcription Factors
2
2017
1628
0.080
 Why?
Anilides
1
2010
73
0.080
 Why?
Apoptosis
5
2019
2425
0.080
 Why?
Societies, Medical
1
2014
741
0.080
 Why?
Surgeons
1
2014
259
0.080
 Why?
Medical Futility
1
2010
24
0.080
 Why?
Disease Models, Animal
1
2019
3936
0.080
 Why?
RNA-Binding Proteins
1
2013
388
0.080
 Why?
DNA Methylation
2
2021
604
0.080
 Why?
Patient Discharge
1
2016
850
0.080
 Why?
Phenotype
2
2015
3039
0.080
 Why?
Electrolytes
1
2009
58
0.080
 Why?
T-Lymphocytes
2
2018
1921
0.080
 Why?
Pediatric Nursing
1
2009
39
0.080
 Why?
Antibodies, Neoplasm
1
2009
35
0.080
 Why?
Surveys and Questionnaires
1
2021
5353
0.080
 Why?
Intracranial Arteriovenous Malformations
1
2009
50
0.080
 Why?
Claudins
1
2009
25
0.080
 Why?
Radiotherapy Dosage
1
2009
250
0.080
 Why?
RNA, Neoplasm
1
2009
87
0.080
 Why?
United States
6
2019
13785
0.080
 Why?
Contractile Proteins
1
2008
15
0.080
 Why?
Quality of Life
2
2015
2672
0.080
 Why?
Medical Records
1
2009
170
0.080
 Why?
Apoptosis Regulatory Proteins
1
2009
181
0.080
 Why?
Sodium
1
2009
202
0.080
 Why?
Point Mutation
1
2009
221
0.070
 Why?
Salvage Therapy
1
2009
133
0.070
 Why?
Fluid Therapy
1
2009
134
0.070
 Why?
Polymorphism, Single Nucleotide
2
2013
2059
0.070
 Why?
Obesity
2
2019
2859
0.070
 Why?
Microtubule-Associated Proteins
1
2009
189
0.070
 Why?
Recovery of Function
1
2012
630
0.070
 Why?
Catheterization
1
2008
171
0.070
 Why?
Neoplasm Grading
2
2021
283
0.070
 Why?
Real-Time Polymerase Chain Reaction
3
2014
323
0.070
 Why?
Microfilament Proteins
1
2008
125
0.070
 Why?
DNA Modification Methylases
1
2007
15
0.070
 Why?
Vertebral Artery Dissection
1
2007
24
0.070
 Why?
Vertebral Artery
1
2007
25
0.070
 Why?
Middle Aged
9
2020
30813
0.070
 Why?
DNA Repair Enzymes
1
2007
21
0.070
 Why?
Autopsy
2
2012
92
0.070
 Why?
Dacarbazine
1
2007
94
0.070
 Why?
Antineoplastic Agents, Alkylating
1
2007
69
0.070
 Why?
Colorado
3
2019
4369
0.070
 Why?
Metabolic Clearance Rate
1
2007
108
0.070
 Why?
Pyrimidines
1
2010
446
0.070
 Why?
Consensus
1
2010
607
0.070
 Why?
Disease-Free Survival
3
2016
647
0.070
 Why?
Disease Progression
3
2012
2598
0.060
 Why?
Vascular Diseases
1
2009
232
0.060
 Why?
Mice
6
2024
16574
0.060
 Why?
Prostheses and Implants
1
2007
132
0.060
 Why?
Infusions, Intravenous
1
2007
390
0.060
 Why?
Nerve Tissue Proteins
1
2009
569
0.060
 Why?
Computer Simulation
2
2021
936
0.060
 Why?
Cell Cycle
3
2014
580
0.060
 Why?
Tumor Cells, Cultured
2
2019
930
0.060
 Why?
Malformations of Cortical Development
1
2025
14
0.060
 Why?
Proteomics
1
2012
1008
0.060
 Why?
Athletic Injuries
1
2012
506
0.060
 Why?
Cranial Fontanelles
1
2024
4
0.060
 Why?
Embolization, Therapeutic
1
2007
205
0.060
 Why?
Spinal Cord Compression
1
2024
17
0.060
 Why?
Animals
8
2024
34487
0.060
 Why?
Drug Synergism
2
2017
356
0.060
 Why?
Age Factors
3
2019
3100
0.060
 Why?
Pregnancy
4
2022
6355
0.060
 Why?
Signal Transduction
2
2015
4812
0.060
 Why?
Gene Expression
4
2015
1454
0.060
 Why?
Xenograft Model Antitumor Assays
2
2019
809
0.060
 Why?
Tumor Microenvironment
2
2022
620
0.060
 Why?
Thoracic Vertebrae
2
2003
74
0.060
 Why?
X-ray Repair Cross Complementing Protein 1
1
2023
14
0.050
 Why?
Endothelial Cells
1
2009
700
0.050
 Why?
Intelligence Tests
1
2023
58
0.050
 Why?
Bleomycin
2
2009
240
0.050
 Why?
Chromosomes
1
2024
101
0.050
 Why?
Twins, Conjoined
1
2003
6
0.050
 Why?
Cranial Irradiation
1
2023
68
0.050
 Why?
Survival
1
2003
39
0.050
 Why?
Stereotaxic Techniques
1
2003
38
0.050
 Why?
Fluorouracil
1
2024
197
0.050
 Why?
Palliative Care
1
2010
714
0.050
 Why?
Diagnosis, Differential
2
2012
1408
0.050
 Why?
Up-Regulation
2
2016
822
0.050
 Why?
Multivariate Analysis
2
2017
1492
0.050
 Why?
Conservative Treatment
1
2022
33
0.050
 Why?
Action Potentials
1
2025
468
0.050
 Why?
Gene Ontology
1
2021
48
0.050
 Why?
Vitamin K Deficiency
1
2000
9
0.040
 Why?
Genetic Markers
1
2002
338
0.040
 Why?
Disseminated Intravascular Coagulation
1
2000
29
0.040
 Why?
Hedgehog Proteins
1
2022
187
0.040
 Why?
DNA Copy Number Variations
1
2021
169
0.040
 Why?
Proportional Hazards Models
2
2015
1194
0.040
 Why?
Cluster Analysis
2
2013
477
0.040
 Why?
Preoperative Period
1
2020
113
0.040
 Why?
Databases, Factual
2
2016
1264
0.040
 Why?
Herpes Simplex
1
2000
93
0.040
 Why?
Fatal Outcome
1
2000
299
0.040
 Why?
Risk Assessment
2
2019
3223
0.040
 Why?
Diseases in Twins
1
2000
176
0.040
 Why?
Perinatal Death
1
2019
22
0.040
 Why?
Spinal Fusion
1
2002
230
0.040
 Why?
Aged, 80 and over
3
2018
7029
0.040
 Why?
Cross-Sectional Studies
1
2010
5034
0.040
 Why?
Antibiotics, Antineoplastic
1
1999
120
0.040
 Why?
Lymphocytes, Tumor-Infiltrating
2
2012
210
0.040
 Why?
Neuropsychological Tests
1
2023
1001
0.040
 Why?
DNA, Antisense
1
1998
3
0.040
 Why?
Mice, SCID
1
2019
350
0.040
 Why?
Heparan Sulfate Proteoglycans
1
1998
21
0.040
 Why?
Radiotherapy, Conformal
1
2019
70
0.040
 Why?
Cysts
1
1999
108
0.040
 Why?
Heparitin Sulfate
1
1998
41
0.040
 Why?
Stroke
1
2007
1063
0.040
 Why?
Cytoreduction Surgical Procedures
1
2019
61
0.040
 Why?
Hemispherectomy
1
2018
3
0.040
 Why?
Brain Diseases
1
1999
136
0.040
 Why?
Radiography
1
2000
794
0.040
 Why?
Proteoglycans
1
1998
109
0.040
 Why?
Fetus
1
2022
760
0.040
 Why?
Mutation
3
2014
3682
0.040
 Why?
Mice, Inbred NOD
1
2019
586
0.040
 Why?
Carboplatin
1
1998
140
0.040
 Why?
Neoplasms, Experimental
1
1998
169
0.040
 Why?
Drug Approval
1
2018
86
0.040
 Why?
Vincristine
1
1998
109
0.040
 Why?
Receptors, HIV
1
2017
26
0.040
 Why?
Mucin-1
1
2017
20
0.040
 Why?
Receptors, Interleukin-6
1
2017
37
0.040
 Why?
Cytogenetic Analysis
1
2017
33
0.040
 Why?
Rhabdomyoma
1
2017
9
0.040
 Why?
Angiomyolipoma
1
2017
18
0.030
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2017
54
0.030
 Why?
Fibroblast Growth Factors
1
1998
170
0.030
 Why?
Drug Administration Schedule
1
2019
755
0.030
 Why?
Headache
1
1998
137
0.030
 Why?
Ki-67 Antigen
1
2017
107
0.030
 Why?
Glial Fibrillary Acidic Protein
1
2017
92
0.030
 Why?
Models, Theoretical
1
2020
541
0.030
 Why?
Antineoplastic Agents, Phytogenic
1
1998
185
0.030
 Why?
Heart Neoplasms
1
2017
49
0.030
 Why?
Carcinoma
2
2014
215
0.030
 Why?
Neovascularization, Pathologic
1
1998
289
0.030
 Why?
Benzodiazepinones
1
2016
16
0.030
 Why?
Tertiary Care Centers
1
2017
146
0.030
 Why?
Clinical Decision-Making
1
2019
302
0.030
 Why?
Organ Size
1
2017
440
0.030
 Why?
Genes, myc
1
2016
50
0.030
 Why?
Urea
1
2016
75
0.030
 Why?
Microscopy, Confocal
1
2017
307
0.030
 Why?
Genotype
2
2012
1828
0.030
 Why?
Gestational Age
1
2019
868
0.030
 Why?
Southwestern United States
1
2015
91
0.030
 Why?
Thiophenes
1
2016
118
0.030
 Why?
Computational Biology
1
2020
595
0.030
 Why?
Transcriptional Activation
1
2017
355
0.030
 Why?
Amphiregulin
1
2015
25
0.030
 Why?
Cats
1
2015
209
0.030
 Why?
Specimen Handling
1
2016
163
0.030
 Why?
Molecular Targeted Therapy
1
2018
384
0.030
 Why?
Feasibility Studies
1
2018
860
0.030
 Why?
Lipopolysaccharide Receptors
1
2015
87
0.030
 Why?
Neoplasm Metastasis
1
2017
608
0.030
 Why?
Dogs
1
2015
368
0.030
 Why?
Cisplatin
1
2016
297
0.030
 Why?
DNA Damage
1
2016
363
0.030
 Why?
Health Status
1
2019
747
0.030
 Why?
Azepines
1
2014
88
0.030
 Why?
Imaging, Three-Dimensional
1
2017
529
0.030
 Why?
Cost of Illness
1
2015
277
0.030
 Why?
Receptors, IgG
1
2013
74
0.030
 Why?
Sequence Analysis, DNA
1
2016
771
0.030
 Why?
Monitoring, Physiologic
1
2015
264
0.030
 Why?
Cathepsin B
1
2012
14
0.030
 Why?
Pyrazoles
1
2016
401
0.030
 Why?
Rapamycin-Insensitive Companion of mTOR Protein
1
2012
28
0.030
 Why?
Promoter Regions, Genetic
1
2017
1198
0.030
 Why?
Argonaute Proteins
1
2012
28
0.030
 Why?
Kansas
1
2012
29
0.030
 Why?
Triazoles
1
2014
150
0.030
 Why?
Missouri
1
2012
70
0.030
 Why?
Karnofsky Performance Status
1
2012
38
0.030
 Why?
Cyclin-Dependent Kinase 6
1
2012
38
0.020
 Why?
Exons
1
2013
338
0.020
 Why?
HLA-DR Antigens
1
2013
224
0.020
 Why?
Mice, Nude
1
2014
675
0.020
 Why?
Logistic Models
1
2017
1975
0.020
 Why?
Monocytes
1
2015
546
0.020
 Why?
Resuscitation
1
1994
234
0.020
 Why?
Hyalin
1
2012
7
0.020
 Why?
3' Untranslated Regions
1
2012
139
0.020
 Why?
Carbonic Anhydrases
1
2012
14
0.020
 Why?
Inflammation Mediators
1
2015
495
0.020
 Why?
Catalase
1
2012
128
0.020
 Why?
CREB-Binding Protein
1
2011
27
0.020
 Why?
Aged
3
2018
21892
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2012
313
0.020
 Why?
Neoplasm Invasiveness
1
2012
477
0.020
 Why?
Neural Stem Cells
1
2012
141
0.020
 Why?
Phosphorylation
1
2015
1681
0.020
 Why?
Aurora Kinases
1
2010
29
0.020
 Why?
Twins, Monozygotic
1
2011
209
0.020
 Why?
Gastrostomy
1
2011
110
0.020
 Why?
Aurora Kinase A
1
2010
55
0.020
 Why?
Liver Cirrhosis
1
2012
279
0.020
 Why?
Physical Examination
1
2011
230
0.020
 Why?
DNA-Binding Proteins
1
2017
1421
0.020
 Why?
Antidiuretic Agents
1
2009
7
0.020
 Why?
Deamino Arginine Vasopressin
1
2009
11
0.020
 Why?
Hypernatremia
1
2009
9
0.020
 Why?
KRIT1 Protein
1
2009
5
0.020
 Why?
Skin Neoplasms
1
2017
818
0.020
 Why?
Repressor Proteins
1
2012
399
0.020
 Why?
Hyponatremia
1
2009
40
0.020
 Why?
High-Throughput Nucleotide Sequencing
1
2012
484
0.020
 Why?
Non-alcoholic Fatty Liver Disease
1
2012
258
0.020
 Why?
Carrier Proteins
1
2012
730
0.020
 Why?
Enzyme Inhibitors
1
2012
809
0.020
 Why?
Cell Division
1
2010
777
0.020
 Why?
Electronic Health Records
1
2016
973
0.020
 Why?
Filamins
1
2008
28
0.020
 Why?
DNA Mutational Analysis
1
2009
384
0.020
 Why?
Cell Movement
1
2012
933
0.020
 Why?
Microscopy, Electron, Transmission
1
2008
142
0.020
 Why?
Fibrous Dysplasia, Monostotic
1
1987
1
0.020
 Why?
Fibrous Dysplasia of Bone
1
1987
5
0.020
 Why?
Radiotherapy
1
2009
185
0.020
 Why?
Gene Frequency
1
2009
504
0.020
 Why?
Spinal Diseases
1
1987
48
0.020
 Why?
Cerebral Angiography
1
2007
109
0.020
 Why?
Etoposide
1
2007
148
0.020
 Why?
DNA, Neoplasm
1
2007
159
0.020
 Why?
Gene Silencing
1
2007
183
0.020
 Why?
Dose-Response Relationship, Drug
1
2010
1943
0.020
 Why?
RNA
1
2012
881
0.020
 Why?
Magnetic Resonance Angiography
1
2007
235
0.010
 Why?
Lung Neoplasms
1
2017
2327
0.010
 Why?
Anticoagulants
1
2007
615
0.010
 Why?
Instillation, Drug
1
1999
10
0.010
 Why?
Injections, Intralesional
1
1999
34
0.010
 Why?
Fibroblast Growth Factor 7
1
1998
16
0.010
 Why?
Fibroblast Growth Factor 10
1
1998
24
0.010
 Why?
Growth Substances
1
1998
150
0.010
 Why?
Fibroblast Growth Factor 2
1
1998
85
0.010
 Why?
Neoplasm Transplantation
1
1998
257
0.010
 Why?
Melanoma, Experimental
1
1998
108
0.010
 Why?
Aging
1
1988
1745
0.010
 Why?
Colonic Neoplasms
1
1998
242
0.010
 Why?
Protein Binding
1
1998
2105
0.010
 Why?
Body Height
1
1988
192
0.000
 Why?
Handler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (494) concept(s)
_
Co-Authors Expand Description
See all (61) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)